Aihua Lin

机构：Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine · ORCID：0000-0002-1157-7249

发表论文 246 篇 · 总被引 10055 次 · h-index 51

代表论文

• Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial (2024 · The Lancet · 被引 185)
• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 72)
• Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors (2023 · American Journal of Psychiatry · 被引 70)
• Shared genetic architecture between irritable bowel syndrome and psychiatric disorders reveals molecular pathways of the gut-brain axis (2023 · Genome Medicine · 被引 45)
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial (2025 · Cancer Cell · 被引 40)
• Multivariate genetic analysis of personality and cognitive traits reveals abundant pleiotropy (2023 · Nature Human Behaviour · 被引 39)